|
|
Influence of premixed insulin and insulin pump on the clinical effect and the time of reaching the standard of blood glucose in patients with diabetes |
WANG Ming |
Department of Endocrinology,Iron and Coal General Hospital of Liaoning Health Industry Group,Liaoning Province,Diaobingshan 112700,China |
|
|
Abstract Objective To investigate the influence of premixed insulin and insulin pump on the clinical effect and the time to reach the blood glucose standard in patients with diabetes.Methods A total of 136 patients with diabetes who were admitted to the Endocrinology Department of Iron and Coal General Hospital of Liaoning Health Industry Group from December 2018 to October 2019 were selected as the research subjects.According to the different methods of administration,divided the patients into control group and study group ,with 68 cases in each group.The control group was treated with Insulin Aspart 30 and the study group was treated with insulin pump Insulin Aspart.The clinical effect and the time to reach the blood glucose standard were compared between the two groups.Results There was no significant difference in fasting blood glucose before treatment and 2 h postprandial blood glucose between the two groups(P>0.05).Half a month after treatment,fasting blood glucose and 2 h postprandial blood glucose in the two groups were lower than those before treatment,the differences were statistically significant(P<0.05),and the fasting blood glucose and 2 h postprandial blood glucose in the study group were lower than those in the control group(P<0.05).The time of reaching the standard of blood glucose was shorter than that in the control group,and the dosage of insulin in the study group was less than that in the control group,the differences were statistically significant(P<0.05).The cost of insulin in the study group was lower than that in the control group,but the total cost of consumables was higher than that in the control group,the differences were statistically significant(P<0.05).Conclusion Insulin pump infusion of Insulin Aspart in the treatment of diabetic patients,can reduce the use of insulin under the condition of better blood glucose control effect,this way is worth recommending.
|
Received: 01 July 2020
|
|
|
|
[1] |
管玉成,吕梦林.预混胰岛素与胰岛素泵对糖尿病患者的效果及血糖达标时间影响评价[J].糖尿病天地,2020,17(4):104.
|
[2] |
赵艾苹,袁百祥.预混胰岛素与胰岛素泵对糖尿病患者的效果观察及血糖达标时间影响分析[J].饮食保健,2020,7(7):92.
|
[3] |
王炜炜.胰岛素四针强化注射或预混胰岛素治疗与胰岛素泵强化治疗对2 型糖尿病临床治疗效果比较[J].临床军医杂志,2020,48(3):335-337.
|
[4] |
温维斌.预混胰岛素与胰岛素泵对糖尿病患者的效果观察及血糖达标时间影响分析[J].临床医药文献电子杂志,2020,7(23):152,154.
|
[5] |
訾丽芳,陶增胜,刘晓辉.胰岛素泵在妊娠期糖尿病及糖尿病合并妊娠患者孕期的应用分析[J].世界最新医学信息文摘(连续型电子期刊),2019,19(1):109,127.
|
[6] |
何士静.比较胰岛素泵泵注门冬胰岛素(诺和锐)与皮下注射重组人胰岛素预混(诺和灵30R)对妊娠期糖尿病(GDM)孕妇的降糖效果及对妊娠结局的影响[J].糖尿病天地,2019,16(2):203.
|
[7] |
董学美,王丽娟,沈鸿,等.胰岛素剂量调整在接受胰岛素泵治疗的2 型糖尿病患者血糖控制中的应用[J].吉林大学学报(医学版),2018,44(6):1280-1285.
|
[8] |
刘效荣,侯娟,吴燕,等.短期胰岛素泵强化降糖治疗对2 型糖尿病患者胱抑素C 及同型半胱氨酸的影响[J].糖尿病新世界,2019,22(8):6-8,11.
|
[9] |
熊芳.预混胰岛素与胰岛素泵对糖尿病患者的应用价值体会[J].糖尿病新世界,2019,22(12):66-68.
|
[10] |
时芸.胰岛素泵在糖尿病治疗中的疗效观察[J].饮食保健,2019,6(42):10.
|
[11] |
杨志贵.预混胰岛素与胰岛素泵对糖尿病患者的应用效果分析[J].中国继续医学教育,2017,9(36):99-100.
|
[12] |
焦秀芹,贾艳芳,谢瑾.门冬胰岛素泵注治疗妊娠期糖尿病61例临床观察[J].中国药业,2018,27(10):22-25.
|
[13] |
刘婧.胰岛素泵后改为多次皮下注射胰岛素治疗2 型糖尿病的疗效探讨[J].心血管外科杂志(电子版),2018,7(4):738-739.
|
[14] |
李积薇,苏菁菁,朱江.胰岛素泵连续皮下输注治疗肺部感染伴糖尿病的临床效果分析[J].现代诊断与治疗,2018,29(23):3880-3882.
|
[15] |
毛燕.胰岛素泵对早期高血糖2 型糖尿病的临床疗效分析[J].临床医药文献电子杂志,2018,5(35):55,57.
|
|
|
|